Kenji Kashima
Chugai Pharma (United States)(US)
Publications by Year
Research Areas
Lung Cancer Research Studies, CAR-T cell therapy research, Cancer therapeutics and mechanisms, Salivary Gland Tumors Diagnosis and Treatment, Lymphoma Diagnosis and Treatment
Most-Cited Works
- → Human Herpesvirus 6 DNA in Plasma after Allogeneic Stem Cell Transplantation: Incidence and Clinical Significance(2005)187 cited
- → CH7233163 Overcomes Osimertinib-Resistant EGFR-Del19/T790M/C797S Mutation(2020)173 cited
- → Chronic Thyroiditis as a Favorable Prognostic Factor in Papillary Thyroid Carcinoma(1998)173 cited
- → DNA Damage-Induced Phosphorylation of MdmX at Serine 367 Activates p53 by Targeting MdmX for Mdm2-Dependent Degradation(2005)131 cited
- → Genetic alterations in 102 primary gastric cancers by comparative genomic hybridization: gain of 20q and loss of 18q are associated with tumor progression(2004)96 cited
- → Aberrant Nuclear/Cytoplasmic Localization and Gene Mutation of β-Catenin in Classic Pulmonary Blastoma(2004)94 cited